Evidence map›Paper›PMID 32845958›Full record

ArticleThe Journal of experimental medicine2020

A loss-of-function NUAK2 mutation in humans causes anencephaly due to impaired Hippo-YAP signaling.

Carine Bonnard, Naveenan Navaratnam, Kakaly Ghosh, Puck Wee Chan, Thong Teck Tan, Oz Pomp, Alvin Yu Jin Ng, Sumanty Tohari, Rishita Changede, David Carling and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Diagnostics (Basel, Switzerland) · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. A fetal oncogene NUAK2 is an emerging therapeutic target in glioblastoma.bioRxiv : the preprint server for biology · 2025
    Article
  16. Review
  17. NUAK: never underestimate a kinase.Essays in biochemistry · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Carine BonnardHuman Genetics and Embryology Laboratory, Institute of Medical Biology, Agency for Science, Technology and Research, Singapore.
Naveenan NavaratnamMedical Research Council London Institute of Medical Sciences, Imperial College London, Hammersmith Hospital, London, UK.
Kakaly GhoshHuman Genetics and Embryology Laboratory, Institute of Medical Biology, Agency for Science, Technology and Research, Singapore.
Puck Wee ChanHuman Genetics and Embryology Laboratory, Institute of Medical Biology, Agency for Science, Technology and Research, Singapore.
Thong Teck TanHuman Genetics and Embryology Laboratory, Institute of Medical Biology, Agency for Science, Technology and Research, Singapore.
Oz PompHuman Genetics and Embryology Laboratory, Institute of Medical Biology, Agency for Science, Technology and Research, Singapore.
Alvin Yu Jin NgInstitute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore.
Sumanty TohariInstitute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore.
Rishita ChangedeMechanobiology Institute, National University of Singapore, Singapore.
David CarlingMedical Research Council London Institute of Medical Sciences, Imperial College London, Hammersmith Hospital, London, UK.
Byrappa VenkateshInstitute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore.
Umut AltunogluMedical Genetics Department, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.
Hülya KayseriliMedical Genetics Department, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.
Bruno ReversadeHuman Genetics and Embryology Laboratory, Institute of Medical Biology, Agency for Science, Technology and Research, Singapore.
Agency for Science, Technology and Research · SGHammersmith Hospital · GBKoç University · TRNational University of Singapore · SG

Funding

Medical Research Council MC_U120027537
6 · The paper itself

Abstract

Failure of neural tube closure during embryonic development can result in anencephaly, one of the most common birth defects in humans. A family with recurrent anencephalic fetuses was investigated to understand its etiology and pathogenesis. Exome sequencing revealed a recessive germline 21-bp in-frame deletion in NUAK2 segregating with the disease. In vitro kinase assays demonstrated that the 7-amino acid truncation in NUAK2, a serine/threonine kinase, completely abrogated its catalytic activity. Patient-derived disease models including neural progenitor cells and cerebral organoids showed that loss of NUAK2 activity led to decreased Hippo signaling via cytoplasmic YAP retention. In neural tube-like structures, endogenous NUAK2 colocalized apically with the actomyosin network, which was disrupted in patient cells, causing impaired nucleokinesis and apical constriction. Our results establish NUAK2 as an indispensable kinase for brain development in humans and suggest that a NUAK2-Hippo signaling axis regulates cytoskeletal processes that govern cell shape during neural tube closure.

Indexed as

ActinsActomyosinAdaptor Proteins, Signal TransducingAmino Acid SequenceAnencephalyBase SequenceCell AggregationConsanguinityDown-RegulationFemaleFetusGenes, RecessiveHippo Signaling PathwayHumansLoss of Function MutationMaleActinsActomyosinAdaptor Proteins, Signal TransducingNUAK2 protein, humanProtein Serine-Threonine KinasesTranscription FactorsYAP1 protein, humanYAP-Signaling Proteins

Identifiers

PMID32845958
PMCPMC7953732
OpenAlexW3080941867

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.